Replies to post #2018 on Halozyme Therapeutics Inc (HALO)

[Fred Kadiddlehopper]

Evidently, the broader market does not share your concerns. Honestly, I don't understand the skepticism expressed here regarding the viability of the insulin strategy. R. Kirk wants in at $10.61 to the tune of $15 million. Personally I have few worries as to where this is ultimately going. AIMHO.
Good luck!
-Fritz